Emboline created a medical device that reduces the risk of brain damage from bypass surgery, heart valve replacement, electrophysiology ablation, etc. Not only for the brain, the patented Emboline technology is the only one that currently also protects downstream systems, including the kidneys. Emboline recently closed their Series D and will use the funds to support US-based pivotal trials for FDA approval, as well as run investigational studies.